Search for: "LUPIN, LTD."
Results 41 - 60
of 131
Sort by Relevance
|
Sort by Date
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
8 Mar 2013, 2:39 am
Ltd. v. [read post]
7 Feb 2013, 1:25 pm
Lupin, Ltd., et al., C.A. [read post]
4 Jan 2013, 2:54 pm
Lupin, Ltd., 499 F.3d 1293, 1300 (Fed. [read post]
23 Dec 2012, 11:00 am
(However in this article available on Pharmabiz here, P.A.Francis argues why he thinks this is an industry friendly policy after all).One view from the industry seems quite favourable to the policy, Shakti Chakraborthy, the President of Lupin Ltd Group while commenting on the policy stated, “It is a good thing that the government has chosen to adopt a market-based mechanism as against a cost-based mechanism, thus protecting industry interest to a large extent as also ensuring… [read post]
2 Dec 2012, 8:32 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals, Inc. [read post]
21 Nov 2012, 11:32 am
Lupin Ltd., C.A. [read post]
16 Aug 2012, 8:42 am
Lupin, Ltd., 499 F.3d 1293, 1302 (Fed. [read post]
14 Aug 2012, 9:26 am
Lupin Ltd. et al. [read post]
3 Aug 2012, 9:51 am
Lupin Ltd. [read post]
30 Jul 2012, 9:55 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
11 Jul 2012, 1:00 am
Lupin Ltd., the Federal Circuit addressed the impact of an unusual patent prosecution history, and held that even erroneously issued claims are entitled to a presumption of validity under 35 USC § 282. [read post]
3 Jul 2012, 8:18 pm
Lupin Ltd., the Federal Circuit vacated a preliminary injunction against ANDA-filer Lupin that blocked its sale of generic Fortamet, and remanded the case to the District Court for the District of Delaware for further processing. [read post]
23 May 2012, 9:22 pm
Searle, LLC • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
26 Apr 2012, 1:00 am
Lupin, Ltd., the Federal Circuit upheld the district court’s determination that the Abbreviated New Drug Applications at issue did not infringe the asserted patent related to Yasmin. [read post]
18 Apr 2012, 9:12 pm
Lupin, Ltd. that for an ANDA filing to infringe a method-of-use claim, the proposed label must indicate that the FDA has determined that the drug is safe and effective for the claimed method. [read post]
22 Feb 2012, 5:49 pm
Lupin, Ltd. et al. [read post]
10 Aug 2011, 4:30 am
Lupin Ltd. et al. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc, Cephalon… [read post]
15 Jun 2011, 4:56 am
Lupin Ltd. et al. [read post]
